PapersTrialsTopicsCompoundsCountriesStakeholdersPeopleCoursesEvents
Browse all papers

Latest papers

Long-term efficacy of psilocybin with adjunct psychotherapy in treatment-resistant depressionPsilocybin · Treatment-resistant depressionDrug-drug interactions between psychiatric medications and MDMA or psilocybinMDMA & psilocybin · SafetyAn international mega-analysis of psychedelic drug effects on brain circuit functionCross-compound · NeuroimagingEsketamine in treatment-resistant depression with and without comorbid borderline personalityEsketamine · Treatment-resistant depression

Featured

Road to Access

Science, regulation, and economics on the path to patient access.

01Evidence02Approval03Reimbursement04Delivery05Access—Big Picture
Start the journey
ResultsCompare outcome data across trials and publications.Research SnapshotOne-page overview of trials, participants, papers, and research networks.Clinical GuidelinesTrial-anchored manuals and protocol guidance with competency mapping.Research recapsMonthly evidence summaries with key takeaways.Map of researchLandscape view of trials, compounds, and outcomes.NewsletterWeekly or daily updates on trials, publications, analysis, and more.Research GroupsWorldwide map of psychedelic research centres by region.Research NetworkInteractive co-authorship map of psychedelic researchers.Top papersFind needles in the haystack of psychedelic research per topic.
AskBeta
Pricing
Back to journals
Academic Journal

International Clinical Psychopharmacology

1 Papers Indexed in Blossom

Data updated June 16, 2026

Research Footprint

International Clinical Psychopharmacology has 1 tracked paper indexed in Blossom (2003) from 5 authors, most often covering LSD, across Anxiety Disorders.

Published Papers

Paywallindividual

Clonazepam treatment of lysergic acid diethylamide-induced hallucinogen persisting perception disorder with anxiety features

This open-label study (n=16) suggests that high-potency benzodiazepines like clonazepam (2mg/day for 60 days) may help alleviate Hallucinogen Persisting Perception Disorder (HPPD). The patients reported relief up to four months after treatment. Do note that there was no control group in this study.

Published
March 1, 2003
Journal
International Clinical Psychopharmacology
Authors
Gelkopf, M., Skladman, I., Rudinski, D., Nachshon, H., Bleich, A.

Quick Facts

Papers Indexed
1
h-Index
100
Open Access
No
Publisher
Wolters Kluwer
Country
United States
Website
Visit

The intelligence layer for psychedelic research.

Company

  • About
  • Contact
  • Newsletter

Product

  • Feedback
  • Roadmap
  • Changelog
  • API
  • Partners
  • Clinical Guidelines

Legal

  • Privacy
  • Terms

© 2026 Blossom. All rights reserved.